NUVASIVE INC
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $1.20B | $1.14B | $1.05B | $1.17B | $1.10B | $1.03B |
| Operating income | — | — | — | — | — | — |
| Net income | $40.4M | −$64.1M | −$37.2M | $65.2M | $12.5M | $81.6M |
| Total assets | $2.22B | $2.15B | $2.69B | $1.89B | $1.71B | $1.64B |
| Total liabilities | — | — | — | — | — | — |
| Equity | $868.9M | $795.2M | $918.9M | $915.2M | $834.5M | $795.6M |
| EPS (diluted) | $0.76 | $-1.24 | $-0.72 | $1.23 | $0.24 | $1.48 |
| Shares out. | 51.8M | 51.4M | 52.1M | 51.6M | 51.3M | 50.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- —
- Net margin
- 3.4%
- Return on equity
- 4.7%
- Return on assets
- 1.8%
- Return on capital (ROCE)
- —
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $16.78
- Revenue growth (YoY)
- 5.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Accruals / assets
- −5.8%clean
- Piotroski F-Score
- 5/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 good- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Norwalk Leslie VDirector | Sep 1, 2023 | D | 3,095 | — |
| Kadia SiddharthaDirector | Sep 1, 2023 | D | 3,739 | — |
| Huennekens R ScottDirector | Sep 1, 2023 | D | 1,360 | — |
| Capps Vickie LDirector | Sep 1, 2023 | D | 2,000 | — |
| Wolf Dale A.Officer — SVP, Global Operations | Sep 1, 2023 | D | 8,943 | — |
| Sisitsky NathanielOfficer — SVP & General Counsel | Sep 1, 2023 | D | 22,423 | — |
| Harbaugh Matthew KOfficer — EVP and CFO | Sep 1, 2023 | D | 11,081 | — |
| Farrington MichaelOfficer — SVP, People and Culture | Sep 1, 2023 | D | 3,117 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsSep 1, 2023
- Results of operations · Regulation FD disclosureAug 2, 2023
- Shareholder voteJun 9, 2023
- Other material eventJun 2, 2023
- New financial obligationMay 26, 2023
- Entered a material agreement · Results of operations · New financial obligation · Director / officer change · Regulation FD disclosureMay 10, 2023
- Other material eventMay 3, 2023
- Shareholder vote · Other material eventApr 27, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GSep 11, 2023
- SC 13G/ASCHEDULE 13G/ASep 11, 2023
- EFFECTSep 7, 2023
- EFFECTSep 7, 2023
- EFFECTSep 7, 2023
- EFFECTSep 7, 2023
- EFFECTSep 7, 2023
- EFFECTSep 7, 2023
- SC 13G/ASep 7, 2023
- 4FORM 4 SUBMISSIONSep 5, 2023
- 4FORM 4 SUBMISSIONSep 5, 2023
- 4FORM 4 SUBMISSIONSep 5, 2023
- 4FORM 4 SUBMISSIONSep 5, 2023
- 4FORM 4 SUBMISSIONSep 5, 2023
- 4FORM 4 SUBMISSIONSep 5, 2023